Lv3
276 积分 2024-03-31 加入
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial
1个月前
已完结
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
3个月前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
5个月前
已完结
Uncommon EGFR mutations in advanced non-small cell lung cancer
5个月前
已完结
Capecitabine as Maintenance Therapy for High-Risk, Resected Colorectal Cancer
6个月前
已完结
Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study
6个月前
已完结
Maintenance treatment in metastatic colorectal cancer: in search of the best strategy
6个月前
已完结
Capecitabine maintenance therapy in metastatic colorectal cancer patients with no evidence of disease: CAMCO trial
6个月前
已完结
Maintenance treatment with oral anticancer agents after first-line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
6个月前
已完结
Cadonilimab: First Approval
6个月前
已完结
皖公网安备34019202002308
